myTomorrows

What myTomorrows does

myTomorrows is a global health technology platform founded in 2012 and headquartered in Amsterdam, Netherlands, that connects patients with serious diseases to clinical trials and expanded access programs (EAPs) worldwide. The company operates a three-sided marketplace serving patients and caregivers (free), healthcare professionals (free), and BioPharma companies (paid), with a footprint spanning 134+ countries and 16,900+ patients served. Core products include an AI-powered treatment search engine that aggregates ClinicalTrials.gov, ISCRTN, and EU Clinical Trials Register data; a Patient Navigation service staffed by medically-trained navigators; an Expanded Access Program (EAP) management platform; and Real-World Data services. Proprietary AI technology includes an LLM-based clinical trial matching tool claiming 98% precision accuracy and an EHR-integrated pre-screening engine deployed at partner sites such as Clínica Universidad de Navarra.

myTomorrows generates revenue through B2B services to BioPharma companies including clinical trial recruitment support, full-service Expanded Access Program management (regulatory submissions, drug supply coordination, safety reporting), and real-world data collection for regulatory and payor objectives. The company also supplies medicinal products for expanded access programs and similar regulatory pathways to pharmacies, hospitals, and distributors. Services to patients and healthcare professionals are provided free of charge, with the freemium model functioning as a top-of-funnel acquisition channel for enterprise contracts.

The company is regulated under European Manufacturing & Importation Authorization and Wholesale Distributor Authorization from the Dutch Ministry of Health (VWS), holding GMP and GDP compliance certifications, plus ISO 27001, SOC 2 Type I, and GDPR certifications. Strategic partnerships include integrations with b.well Connected Health (2.4M providers), Clínica Universidad de Navarra (200+ trials), Rare Disease Research (SE US), and Sentynl Therapeutics (Managed Access Programs). The company received a €25 million growth investment from Avego Healthcare Capital in November 2025 and was selected for the AWS Pioneers Project 2026.

Name

myTomorrows

Legal name

Impatients N.V.

Website

https://mytomorrows.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

myTomorrows is a global health technology platform that connects patients with serious diseases to clinical trials and expanded access programs across 134+ countries, serving BioPharma clients through AI-powered trial matching, EAP management, and real-world data services while offering free patient navigation.

Ownership category

akta.pro rank

Product category

Clinical Trial Access Platform

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC)

akta.pro secondary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

• Clinical trial recruitment
• Expanded access programs
• Patient navigation services
• Real-world data services
• Pharmaceutical access platform

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. BioPharma services - Clinical trial recruitment: myTomorrows provides patient recruitment support services to pharmaceutical companies for clinical trials, helping reduce recruitment timelines and screening costs
2. Expanded Access Program management: Full-service EAP management services for BioPharma including program design, regulatory compliance, drug supply, and distribution
3. Real-World Data services: Specialized RWD services for pharmaceutical companies to collect observational data supporting regulatory and payor objectives
4. Medicinal product supply for expanded access: Supply of medicinal products for expanded access programs, similar regulatory pathways, or off-label use to pharmacies, hospitals, and local distributors
5. Patient platform services: Free services provided to patients and healthcare professionals for discovering and accessing treatments in development

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

myTomorrows operates a global platform that connects patients with serious diseases and their physicians to treatments in development, including clinical trials and expanded access programs, supported by medically-trained Patient Navigators. For BioPharma clients, the company provides clinical trial recruitment services, full-service Expanded Access Program (EAP) management, a purpose-built Expanded Access Management Platform, and Real-World Data services, underpinned by an AI-powered clinical trial matching tool with reported 98% precision accuracy.

Product overview

myTomorrows operates as a unified health technology platform connecting patients, physicians, and bioPharma companies for pre-approval treatment access. The platform consists of an AI-powered Treatment Search Engine that searches global clinical trial databases, combined with Patient Navigation Services staffed by medically-trained navigators. For bioPharma clients, the company offers Clinical Trial Recruitment Services, Expanded Access Services, an Expanded Access Management Platform, Real-World Data Services, and Managed Access Programs. Key AI features include an AI Clinical Trial Matching Tool achieving 98% precision accuracy and AI-Assisted Patient-Trial Matching integrated into hospital EHR systems. The platform supports patients across 134 countries and early access to over 10,000 therapies in development.

Differentiator

Problem solved

Functional benefit

Products and services

• AI Treatment Search Engine AI-powered search engine that enables patients and physicians to discover clinical trials and expanded access programs across multiple global registries. Provided to patients and healthcare professionals at no cost via the myTomorrows platform.
• Patient Navigation Services Personalized support service staffed by medically-trained Patient Navigators who guide patients and caregivers through treatment discovery, eligibility assessment, and access to pre-approval treatments. Free of charge to patients.
• Clinical Trial Recruitment Services Patient recruitment support services for clinical trials, helping pharmaceutical sponsors reduce recruitment timelines, lower screening costs, and enroll more diverse patient populations.
• Expanded Access Services Full-service Expanded Access Program management for BioPharma clients covering program design, regulatory compliance, physician engagement, drug supply coordination, and safety reporting.
• Expanded Access Management Platform Purpose-built technology platform that supports BioPharma expanded access operations with workflow management, compliance, traceability, and regulatory coordination.
• Real-World Data Services Specialized services that collect and analyze Real-World Data from expanded access programs to support BioPharma regulatory and payor objectives.
• Managed Access Program Program management service for BioPharma companies to provide patient access to treatments outside of clinical trials, including compassionate use and named patient programs.
• Medicinal Product Supply for Expanded Access Transactional supply of investigational or authorized medicinal products for expanded access, similar regulatory pathways, or off-label use to pharmacies, hospitals, and local distributors, operated under GMP/GDP compliance.

Quantifiable outcome

• 500% revenue growth over four years
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Partnerships

Six partnerships are on record, tiered flagship and core.

• b.well Connected HealthflagshipTechnology or Integration · 26 May 2026Strategic partnership to launch AI-driven clinical trial matching platform combining b.well's FHIR-based health data network (2.4M providers, 330 health plans, multiple state HIEs) with myTomorrows' AI-powered pre-screening engine. Aims to automate patient matching, reduce recruitment timelines, lower screening costs, and enroll diverse populations
• Rare Disease ResearchcoreStrategic or Co-development Partner · 16 April 2026Partnership to improve rare disease patient identification and referral into clinical trials through structured referral pathway. Initially supporting research sites in Georgia, Florida, and North Carolina, enabling referring physicians to submit qualified referrals directly to RDR site teams
• CUNcoreStrategic or Co-development Partner · 27 March 2026Partnership on AI-assisted patient trial matching technology development
• Clínica Universidad de Navarra (CUN)coreStrategic or Co-development Partner · 26 March 2026First large-scale site partnership in Spain implementing AI-assisted patient-trial matching across CUN's portfolio of 200+ active clinical trials. System uses LLM to analyze clinical variables integrated directly into CUN's EHR and CTMS. Includes CUN-branded referral platform for external physicians
• Amazon Web Services (AWS)coreTechnology or Integration · 17 March 2026Selected for AWS Pioneers Project 2026, recognizing the company's AI innovation in healthcare for advancing Europe's competitiveness through purposeful innovation
• Sentynl TherapeuticscoreStrategic or Co-development Partner · 10 December 2025Sentynl transitioned its Managed Access Program to myTomorrows to improve access to treatments for rare diseases, including ultra-rare conditions like Hutchinson-Gilford Progeria Syndrome. Partnership aims to expand program reach and improve access to therapies

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Clara Health: Patient navigation and clinical trial concierge service for patients and sponsors; overlaps with myTomorrows' Patient Navigator offering and sponsor recruitment business model.
• Mendel: AI platform that structures clinical data and matches patients to trials and cohorts; comparable technology (LLM + clinical NLP) and sells to both health systems and life sciences sponsors.
• Massive Bio: AI-driven clinical trial matching and patient recruitment for oncology; competes head-to-head with myTomorrows on pharma-sponsored patient recruitment, particularly in the US, and serves a similar BioPharma buyer.
• Deep 6 AI: AI clinical trial matching platform that mines unstructured EHR data to match patients to trials; directly comparable technology approach (LLM on clinical notes) and end customers (health systems and sponsors).
• Antidote: Patient-facing clinical trial matching and digital engagement platform acquired by Thread; competes with myTomorrows on patient recruitment funnels and sponsor recruitment services.

Broad incumbents

• Veeva Systems: Life sciences cloud platform covering clinical, regulatory and commercial workflows; a broad incumbent in the same sponsor IT budget pools myTomorrows targets with its recruitment and EAP services.
• ICON plc: Major global CRO with technology-enabled patient recruitment and post-approval access programs; competing incumbent for enterprise BioPharma contracts myTomorrows targets.
• Parexel International: Global CRO offering patient recruitment, real-world evidence and expanded access services; competes with myTomorrows on the BioPharma services stack, particularly around EAP and RWD.
• IQVIA: Largest global CRO with its own AI-driven trial recruitment and RWD capabilities; represents the broad incumbent that myTomorrows must compete against for enterprise BioPharma master agreements.
• Medidata Solutions: Dassault Systèmes-owned clinical trial technology platform (Rave, eCOA, RTSM); a broad incumbent whose trial informatics stack competes with myTomorrows on sponsor technology spend.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/myTomorrows
• Facebookfacebook.com/mytomorrows
• LinkedInlinkedin.com/company/mytomorrows
• Instagraminstagram.com/myTomorrows

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about myTomorrows